BNTX icon

BioNTech

300 hedge funds and large institutions have $5.78B invested in BioNTech in 2024 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 84 increasing their positions, 85 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

2% more funds holding

Funds holding: 294300 (+6)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

1% less repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 85

Holders
300
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$373M
Puts
$269M
Net Calls
Net Calls Change

Top Buyers

1 +$160M
2 +$102M
3 +$70M
4
DZ Bank
DZ Bank
Germany
+$49.4M
5
UBS Group
UBS Group
Switzerland
+$46.3M

Top Sellers

1 -$73.7M
2 -$43M
3 -$29.9M
4
Primecap Management
Primecap Management
California
-$25.1M
5
BlackRock
BlackRock
New York
-$24.6M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$5.13M
77
$5.01M
78
$5M
79
$4.75M
80
$4.73M
81
$4.56M
82
$4.56M
83
$4.43M
84
$3.77M
85
$3.51M
86
$3.47M
87
$3.46M
88
$3.37M
89
$3.18M
90
$3.12M
91
$3.1M
92
$2.87M
93
$2.72M
94
$2.72M
95
$2.65M
96
$2.62M
97
$2.44M
98
$2.39M
99
$2.38M
100
$2.33M